Figure 1: Human NSCLC cells A549 and A549Luc are chemoresistant to Dox. Viability of A549 and A549Luc cells was assessed by MTT assay after treatment with doxorubicin for 24 h (A and D), 48 h (B and E) and 72 h (C and F). Data are shown as mean ± SEM.